Report of the american heart association (AHA) scientific sessions 2015, Orlando

Yoshiyasu Aizawa, Mai Kimura, Takashi Kohno, Jun Fujita, Keiichi Fukuda

研究成果: Article査読

2 被引用数 (Scopus)

抄録

The American Heart Association Scientific Sessions were held in Orlando on November 7–15, 2015. The meeting attracted more than 18,000 participants, including physicians, research scientists, students, and paramedical personnel, from more than 100 countries. Sessions over the 5 days included a comprehensive and unparalleled education delivered via more than 5,000 presentations, with 1,000 invited faculty members and 4,000 abstract presentations from the world leaders in cardiovascular disease. It also displayed the newest cardiovascular technology and resources by more than 200 exhibitors. There were 19 trials scheduled in 6 late-breaking clinical trial sessions. The Systolic Blood Pressure Intervention Trial (SPRINT) aimed to determine the most appropriate targets for the systolic blood pressure among persons without diabetes. A total of 9,361 persons with systolic blood pressure of ≥130 mmHg and an increased cardiovascular risk, but without diabetes, were randomly assigned to a target systolic blood pressure of <120 mmHg (intensive treatment) or a target of <140 mmHg (standard treatment). A significantly lower rate of the primary composite outcome and all-cause mortality in the intensive-treatment group than in the standardtreatment group was observed. Summaries and overviews of the late-breaking trials, clinical science special report sessions, and sessions to which members of the Japanese Circulation Society contributed are presented.

本文言語English
ページ(範囲)51-57
ページ数7
ジャーナルCirculation Journal
80
1
DOI
出版ステータスPublished - 2015 12 25

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

フィンガープリント 「Report of the american heart association (AHA) scientific sessions 2015, Orlando」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル